Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Celgene Corporation
Scientific Title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Compare Efficacy and Safety of Oral Azacitidine Plus Best-supportive Care Versus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (Other ID's: CC-486-AML-001, 2012-003457-28)